Discover
LPCN
Lipocine Inc.
2.09
1 x 1.90
1 x 2.23
bid
ask
-
0.01
0.48%
01:31 PM
timesize
| Ytd | -73.97% | |
| 1y | -29.15% |
2.09
day range
2.15
1.81
52 week range
12.37
| Open | 2.15 | Prev Close | 2.10 | Low | 2.09 | High | 2.15 | Mkt Cap | 17.23M |
| Vol | 9.37K | Avg Vol | 73.40K | EPS | -1.79 | P/E | -1.17 | Forward P/E | -3.87 |
| Beta | 0.46 | Short Ratio | 2.80 | Inst. Own | 9.96% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-14 | 50-d Avg | 2.26 | 200-d Avg | 4.56 | 1yr Est | 21.50 |
| Income Statement | |||
| Total Revenue | 190.10K | ||
| Revenues (USD) | 190.10K | ||
| Gross Profit | 190.10K | ||
| Operating Expenses | 3.03M | ||
| Research and Development Expense | 2.04M | ||
| Selling, General and Administrative Expense | 990.96K | ||
| Operating Income | -2.84M | ||
| Income Tax Expense | 200.00 | ||
| Net Income | -2.62M | ||
| Net Income Common Stock | -2.62M | ||
| Net Income Common Stock (USD) | -2.62M | ||
| Consolidated Income | -2.62M | ||
| Earnings per Basic Share | -0.32 | ||
| Earnings per Basic Share (USD) | -0.32 | ||
| Earnings per Diluted Share | -0.32 | ||
| Earning Before Interest & Taxes (EBIT) | -2.62M | ||
| Earning Before Interest & Taxes (USD) | -2.62M | ||
| Weighted Average Shares | 8.22M | ||
| Weighted Average Shares Diluted | 8.22M | ||
| Balance Sheet | |||
| Cash and Equivalents | 4.98M | ||
| Cash and Equivalents (USD) | 4.98M | ||
| Investments | 18.29M | ||
| Investments Current | 18.29M | ||
| Trade and Non-Trade Receivables | 190.10K | ||
| Current Assets | 23.74M | ||
| Property, Plant & Equipment Net | 74.83K | ||
| Total Assets | 23.84M | ||
| Current Liabilities | 2.07M | ||
| Total Liabilities | 2.07M | ||
| Accumulated Retained Earnings (Deficit) | -215.69M | ||
| Accumulated Other Comprehensive Income | -13.40K | ||
| Shareholders Equity | 21.77M | ||
| Shareholders Equity (USD) | 21.77M | ||
| Assets Non-Current | 98.58K | ||
| Deferred Revenue | 320.00K | ||
| Trade and Non-Trade Payables | 680.53K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 14.65K | ||
| Net Cash Flow from Financing | 1.51M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -36.18K | ||
| Issuance (Purchase) of Equity Shares | 1.51M | ||
| Net Cash Flow from Investing | 1.48M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 1.48M | ||
| Net Cash Flow from Operations | -3.03M | ||
| Share Based Compensation | 58.15K | ||